Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

1.68
-0.0600-3.45%
Post-market: 1.720.0400+2.38%19:32 EDT
Volume:97.06K
Turnover:164.66K
Market Cap:2.50M
PE:-0.01
High:1.75
Open:1.75
Low:1.61
Close:1.74
52wk High:524.00
52wk Low:1.43
Shares:1.49M
Float Shares:1.48M
Volume Ratio:0.44
T/O Rate:6.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-175.9200
EPS(LYR):-303.4772
ROE:-114.61%
ROA:-51.35%
PB:0.22
PE(LYR):-0.01

Loading ...

Clearmind Medicine Reaches Major Milestone, Completing Part a Treatment in FDA‑Regulated Phase I/Ii Trial

THOMSON REUTERS
·
Jun 22

HRT Financial LP disposes of $73,191 in Clearmind Medicine common shares

Reuters
·
Jun 19

Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial

TIPRANKS
·
Jun 18

Clearmind Medicine wins US patent for MEAI-based binge behavior regulators

Reuters
·
Jun 18

HRT Financial LP sells 3,183 Clearmind Medicine common shares for $10,567.56

Reuters
·
Jun 18

HRT Financial LP disposes of 2,102 Clearmind Medicine common shares worth $7,062.72

Reuters
·
Jun 16

BRIEF-Clearmind Medicine Completes Dosing For Part A Of Its Of FDA-Regulated Phase I/Ii Clinical Trial

Reuters
·
Jun 16

Clearmind Medicine Completes Dosing in First 4 Cohorts of Phase I/II Alcohol Use Disorder Trial

MT Newswires Live
·
Jun 16

Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder

Reuters
·
Jun 16

Clearmind Medicine Completes Dosing for Part a of Its of FDA-Regulated Phase I/Ii Clinical Trial

THOMSON REUTERS
·
Jun 16

Clearmind Medicine says HRT Financial files initial beneficial ownership statement

Reuters
·
Jun 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM

Reuters
·
Jun 08

Clearmind Medicine spotlights new CMND-100 alcohol use disorder trial data in June 10 webinar

Reuters
·
Jun 05

Clearmind Medicine to Feature New Insights From Cmnd-100 Psychedelic Clinical Trial on “Inside Meai” Webinar

THOMSON REUTERS
·
Jun 05

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

GlobeNewswire
·
Jun 05

Clearmind Medicine to sell $1.5 million in convertible promissory notes at 90% of face value

Reuters
·
Jun 02

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:27 AM

Reuters
·
Jun 01

Top Premarket Decliners

MT Newswires Live
·
Jun 01

Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan

TIPRANKS
·
May 29

Clearmind Medicine files Japanese patent application for MEAI-based depression treatment

Reuters
·
May 29